B. Braun Canada Receives Health Canada Approval for the Space®^plus Infusion System

MISSISSAUGA, ON – August 26, 2026 – B. Braun Canada Ltd. (B. Braun), a leader in smart infusion therapy, today announced that Health Canada has approved the Space^plus Infusion System, the latest advancement in B. Braun's more than 75 years of infusion pump innovation.

Building on the proven performance of the existing Space® platform, the Space^plus system introduces enhancements designed to improve clinical workflows, support patient safety and simplify infusion management. Key features include a larger display with full drug-name visibility, Tall Man Lettering and color-coded medications to help clinicians quickly identify therapies. Its modular design supports configurations ranging from a single pump to 16 pumps on one IV pole and power cord, maximizing space at the bedside.

The system continues to support hospital-wide standardization by integrating both large volume and syringe pumps within a single software platform. The new MRI station can shield up to eight pumps against magnetic fields, helping maintain infusion therapy during imaging procedures. Similar user interfaces across both pump types are designed to reduce programming complexity and streamline staff training.

Additional features include IP44 moisture protection, a touch display that can be operated while wearing gloves and advanced cybersecurity protections.

The Space^plus system is supported by OnlineSuite^plus, B. Braun's centralized digital platform for infusion management. The software integrates with hospital IT systems through a bi-directional HL7-IHE framework and provides a single access point for key digital tools. DoseTrac^plus delivers infusion reporting and insights to support protocol adherence and drug library compliance, while DeviceManager^plus enables remote deployment of software updates, drug libraries and configuration files without disrupting patient care. In addition, DrugLibraryManager^plus offers enhanced customization to support the unique needs of different care settings while maintaining standardized medication management practices.

"The approval of the Space^plus Infusion System marks an important milestone for B. Braun and for infusion therapy in Canada," said Ian Duncalf, Managing Director of B. Braun Canada. "Built on decades of infusion expertise, Space^plus introduces new capabilities that enhance patient safety, simplify clinical workflows and help hospitals and providers adapt to the evolving demands of care delivery."

About B. Braun Canada Ltd.

B. Braun Canada Ltd. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we’re uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Mississauga, Ontario and is part of the B. Braun Group of Companies in the North America, which includes B. Braun Medical Inc., B. Braun Interventional Systems, Aesculap® and CAPS®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Canada, explore our  website.